Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,733,958 papers from all fields of science
Search
Sign In
Create Free Account
mesalamine
Known as:
Mesalazine
, m Aminosalicylic Acid
, 5 asa
Expand
An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
32 relations
24 HR mesalamine 375 MG Extended Release Oral Capsule [Apriso]
Aminosalicylic Acids
Drug Allergy
In Blood
Expand
Narrower (11)
5-Aminosalicylate
Asacol
Asacolitin
Asacolon
Expand
Broader (2)
Anti-Inflammatory Agents, Non-Steroidal
aminosalicylic acid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2007
Review
2007
New physiopathological and therapeutic approaches to diverticular disease of the colon
A. Tursi
Expert Opinion on Pharmacotherapy
2007
Corpus ID: 37871593
Diverticular disease of the colon is among the most common diseases of westernised and industrialised countries. Its prevalence…
Expand
Highly Cited
1999
Highly Cited
1999
Optimum duration of treatment with 6-mercaptopurine for Crohn's disease
Peter S. Kim
,
J. Zlatanic
,
B. Korelitz
,
G. Gleim
American Journal of Gastroenterology
1999
Corpus ID: 2107789
Objective:6-Mercaptopurine (6MP) and azathioprine are immunomodulators used in the treatment of refractory Crohn's disease…
Expand
Highly Cited
1992
Highly Cited
1992
Calcium Alginate Beads as Core Carriers of 5-Aminosalicylic Acid
Shun Y. Lin
,
J. Ayres
Pharmaceutical Research
1992
Corpus ID: 34628947
The utilization of calcium alginate beads as core carriers for delayed dissolution followed by burst release as a potential…
Expand
Highly Cited
1988
Highly Cited
1988
Firefighting and malignant hyperthermia
B. Novis
,
Z. Korzets
,
P. Chen
,
J. Bernheim
British medical journal
1988
Corpus ID: 30830859
Une observation: un homme de 43 ans presentant des taux seriques de creatine kinase tres eleves (650 VI/l) est examine. Les…
Expand
Highly Cited
1984
Highly Cited
1984
Topical treatment of distal ulcerative colitis with 4-amino-salicylic acid enemas.
W. Selby
,
M. Bennett
,
D. Jewell
Digestion
1984
Corpus ID: 46774143
Enemas of 4-amino-salicylic acid (4-ASA) have been compared with placebo enemas in a double-blind study for the treatment of…
Expand
Highly Cited
1983
Highly Cited
1983
Inhibition of soybean lipoxygenase by sulfasalazine and 5-aminosalicylic acid: a possible mode of action in ulcerative colitis.
J. Sircar
,
C. F. Schwender
,
M. E. Carethers
Biochemical Pharmacology
1983
Corpus ID: 29526188
Highly Cited
1983
Highly Cited
1983
Absorption and excretion of a single 1-g dose of azodisal sodium in subjects with ileostomy.
H. Sandberg-Gertzén
,
M. Ryde
,
G. Järnerot
Scandinavian Journal of Gastroenterology
1983
Corpus ID: 31651239
The behaviour of a single 1-g oral dose of azodisal sodium (ADS) given to 10 healthy volunteers with an ileostomy was studied…
Expand
Highly Cited
1980
Highly Cited
1980
A simple method for the purification of 5-aminosalicylic acid. Application of the product as substrate in enzyme-linked immunosorbent assay (ELISA).
D. J. Ellens
,
A. Gielkens
JIM - Journal of Immunological Methods
1980
Corpus ID: 20870927
Highly Cited
1979
Highly Cited
1979
Enzyme-linked immunosorbent microassay for quantification of specific antibodies to collagen type I, II, III.
B. Gosslau
,
H. Barrach
JIM - Journal of Immunological Methods
1979
Corpus ID: 32992191
Highly Cited
1972
Highly Cited
1972
Nephrotoxic Lesions from 5-Aminosalicylic Acid
I. Calder
,
C. Funder
,
C. R. Green
,
K. Ham
,
J. Tange
British medical journal
1972
Corpus ID: 29631250
5-Aminosalicylic acid given to rats as a single intravenous injection led to necrosis of the proximal convoluted tubules and of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE